Insider trades

Peter Ordentlich, Chief Officer of Syndax Pharmaceuticals SNDX, has filed 0 purchases and 3 sales on the open market. The latest trade was on 23/02/15.

Peter Ordentlich

Chief Scientific Officer
First filing
23/02/03
Trades
9 trades
Buys / sales
0 / 3
12-month net buying
No record
Last trade
23/02/15

Trading activity

Transactions

Trade type
SNDX
Open-market sale23/02/1523/02/1725,000 sh2 trades$25.84avg.$646,000−100.0%
Open-market sale23/02/0123/02/0369 sh$28.43$1,961.67−100.0%